Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects
Clinical trial NCT02912377 · COMPLETED
Trial details
- NCT number
- NCT02912377
- Sponsor
- Cinfa Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-05-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.